Lineage Cell Therapeutics (LCTX) EBT Margin (QoQ) (2010 - 2026)
Lineage Cell Therapeutics (LCTX) EBT Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -103,243.00 |
| Dec 31, 2025 | 42,392.00 |
| Sep 30, 2025 | 30,300.00 |
| Jun 30, 2025 | -36,161.00 |
| Mar 31, 2025 | -34,008.00 |
| Dec 31, 2024 | -3,391.00 |
| Sep 30, 2024 | 33,060.00 |
| Jun 30, 2024 | 4,414.00 |
| Mar 31, 2024 | -22,839.00 |
| Dec 31, 2023 | 34,871.00 |
| Sep 30, 2023 | -41,314.00 |
| Jun 30, 2023 | 9,881.00 |
| Mar 31, 2023 | 7,208.00 |
| Dec 31, 2022 | -14,626.00 |
| Sep 30, 2022 | -3,700.00 |
| Jun 30, 2022 | -1,352.00 |
| Mar 31, 2022 | -7,942.00 |
| Dec 31, 2021 | 33,367.00 |
| Sep 30, 2021 | 58,003.00 |
| Jun 30, 2021 | -59,939.00 |